Bergamo Acquisition Corp. BGMO OTC US Bergamo

New Post Public Reply Private Reply Replies (0) Message Board

Apr 13, 2013 at 11:34 PM

Bergamo Acquisition Corp. BGMO OTC US

Bergamo Acquisition Corp., through its wholly owned subsidiary, Bergamo E&A., focuses on the development of energy infrastructure projects in Pakistan. The company involves in the construction of mission-critical infrastructure, including clean energy electric plants, solar renewable energy projects, and LED high efficiency lighting projects. It also provides construction management and facility maintenance services. The company engages in wholesale business that focuses on women’s, men’s, and children’s urban fashion apparel and accessories.

Bergamo Acquisition Corp. (OTC: BGMO) is a Delaware corporation incorporated in 1997. Clothing Source of California Inc. a fully operating company through a reverse merger on June 21st 2002 acquired Bergamo Acquisition Corp making Bergamo Acquisition Corp a fully operating company. The company has engaged investments in financial instruments and companies worldwide. In May of 2012, BGMO purchased 100% interest in a European entity for its investing strategies using the Euro currency. Financials reports have been posted at the following link http://www.otcmarkets.com/stock/BGMO/filings .

Bergamo Acquisition is targeting a diversified portfolio of large corporate and middle-market companies for sole acquisition and co-investment alongside other sophisticated investors such as private equity funds, hedge funds, investment banks, and other institutions. As a source of funding, BGMO will also work alongside company management in effecting management buy-outs, friendly mergers, and value-accretive capital projects. From time to time, the company may provide debt financing as a proprietary investor in the form of bi-laterally negotiated private placements . Bergamo Acquisition has raised investable funds in order to pursue the investment activities listed above. BGMO has sole fiduciary discretion over these funds and will direct their disposition in such a way that it will increase shareholder value for BGMO and its portfolio companies in line with its acquisition strategy.

Bergamo Acquisition is based in Henderson, Nevada, and has affiliated offices in Europe and Asia. BGMO relies on its deep network within the global institutional investment and banking industries to source opportunities. BGMO has taken a 60% interest in Bergamo Energy Inc. of Miami, FL, a provider of solar energy technologies to sovereign and corporate customers in the Asian markets. In order to enhance disclosure and investor interest , BGMO has engaged the accounting firm of L.L. Bradford, based in Las Vegas, Nevada, to audit its financial records

CORRECTION: BGMO.pk BERGAMO ACQUISITION CORP AGREES TO SELL 70% OF SOLAR POWER PROJECT IN SINDH PAKISTAN
Jan 08, 2009

OTC Disclosure & News Service

Henderson, NV -

BGMO.pk Bergamo Acquisition Corp Agrees to Sell 70% of Solar Power Project in Sindh Pakistan

Henderson, NV - Jan 7th - Bergamo Acquisition Corp (BGMO.PK) has organized a public unlisted corp. BERGAMO E&A CORP. BAC, as project manager of a proposed 500 MGW solar energy project in Pakistan, entered into a joint venture proposal to sell, at an agreed price, 70% interest in Bergamo E&A Corp to AES CORP who will have management and construction control.

BAC is supported by a 20 year power purchase agreement with the Government of Pakistan valued at $ 2,245,000,000 billion US dollars. BAC has formed, in Pakistan, a new corporation known as Shahbaz International Investment and Securities Corp (SII&SC), which will receive transfer of profits from the proposed joint venture agreement with AES Corp. Anticipated profits are projected at 2,430,000 per year based on 200 MGW facilities.

SII&SC has also entered into MOU with Arif Habib Bank to pursue joint ventures within Pakistan.

From Jan to April, 2009 SII&SC will have completed plans for projects as below:

-- LED lighting facility
-- Solar Panel manufacturing facility
-- Water Desalinization
-- Dairy Products
-- License with Japanese company to supply products for distribution in Pakistan
-- Commercial Finance and Factoring Company in Conjunction with Bank.

Arif Habib Bank investment division plans to organize an IPO in Pakistan incorporating all of the above developments. BAC, SII&SC and Arif Habib Bank's objectives thru the IPO are to encourage investiment of US dollars in Pakistan through renewable energy and as described above in a number of other projects.

Please refer to prior announcement dated Jan 5th, 2009 and other announcements regarding Government supports agreements at www.pinksheets.com trading symbol bgmo.

Statements included in this release related to Bergamo Acquisition Corp., Inc., may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the ability to locate additional debt or equity financing on reasonable terms, competitive factors, market demand for the Company's products, and the Company's ability to obtain new orders and fulfill them on profitable terms. Further information on potential risk factors that could affect the Company's financial results can be found in the Company's reports filed with the Pink Sheets News Service.

For more information please contact hillardbergamo@aol.com
Hillard Herzog, President, Bergamo Acquisition Corp, Tel 702 269 0820

Source: Bergamo Acquisition Corp.

Bergamo Acquisition Corporation (BGMO) Stock Research Links

BGMO Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...